tirzepatide suicidal ideation FDA clears GLP-1 weight loss drugs of risk | Hesham Sherif posted on the topic An exploratory study evaluating the

In another multicenter, randomized, double-blind, placebo-controlled, parallel-group clinical trial conducted by Suzuki et al

Pre-treatment prevention is not standard practice, but starting proactive hydration the day you begin tirzepatide may reduce symptom severity

Individuals who are prescribed Wegovy generally must meet the following criteria: Adults with BMI 30 (obesity) Adults with BMI 27 (overweight) with a weight-related health condition Children 12 years and older with a BMI in the 95th percentile or higher (obesity) Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist

1995;10 Suppl 2:S8-24